U.S. Markets closed

ZIOPHARM Oncology, Inc. (ZIOP)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
6.100.00 (0.00%)
At close: 4:00PM EDT
People also watch
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue6,8614,3321,373
Cost of Revenue---
Gross Profit6,8614,3321,373
Operating Expenses
Research Development157,791106,78532,706
Selling General and Administrative14,37717,64712,166
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-165,307-120,100-43,499
Income from Continuing Operations
Total Other Income/Expenses Net101211,718
Earnings Before Interest and Taxes-165,297-120,088-31,781
Interest Expense---
Income Before Tax-165,297-120,088-31,781
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-165,297-120,088-31,781
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-165,297-120,088-31,781
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-172,420-120,088-31,781